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OCULAR PENETRATION AND INTRAOCULAR PRESSURE (IOP) 
LOWERING ACTIVITY OF THE AhGIOTENSIN II (AII) ANTAGONISTS 
LOSARTAN AND L-158,338. 
MALLORGA P. AND SUGRUE M.F. 
Merck Sharp % Dohme Research Labs, West-Point, PA 19486,USA. 
&&v,w To assess the penetration of Iossrtan and L-158,338 into the rabbit eye 
after topical application and their effects on the IOP of ocular hypertensive 
cynomolgus monkeys. 
M&Q& Penetration was indirectly assessed in albino rabbits using an & 
assay. Aliquots of aqueous humor were sampled one hour after the bilateral topical 
instillation of one drop (50 uL) of 2% solutions of losartsn or L-158,338 (3H- 
imid~o[4,5-B]pyridine,7-methyl-2-proI~yl-3~[[~-(IH-tetrazol-5-yl)[l,I’-biphenyl]- 
4-yl]methyl]) and their ability to block 1251-[ser,1ie]-~11 (s.4tuLE) binding tc 
binding sites in a membrane fracticn of rabbit iris+ciliary body (ICB) was 
determined. IOP was measured out to six hours using a pneumatic tonometer in 
lightly sedated cynomolgus monkeys in which IOP had previously been 
experimentally elevated by photocoagulating the trabecular meshwork with an argon 
laser. 
&t&x Inhibition constants (Ki) for SARILE binding sites in ICB membranes were 
80 nM and 2 nM for losartan and L-158.338, respectively. These results were in 
good agreement with values found at the ATI receptor subtype. In contrast a value 
of 72,000 nM was found for the AT2 selective compound WL-19. Concentrations in 
the aqueous humor were 50 nM and 120 nM for losertan and L-158,338, 
respectively. These values were 0.6- and 60-fold their respective Ki values. The 
instiilation of 1% solutions of losattan .md L-158,338 did not elicit meaningful and 
consistent reductions in the IOP of ocuhu hypertensive monkeys. Increasing the dose 
of L-158,338 to 2% also failed to lower IOP. 
Conc[usions: AI1 receptors in the rabbit ICB are of the ATI subtype. Both topically 
applied losartan and L-158,338 penetrate into the rabbit eye hut neither agent 
displayed meaningful IOP lowering activity in ocular hypertensive monkeys. 
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EFFECT OF CARTEOLOL ON THE CYTOSKELETON AND 
THE PHAGOCYTOSIS CA.PACITY OF CULTURED 
TJtABECULAR CELLS. 
SECHOY-CHAMBON O., MORLJJ?RE L. and COQUELET C. 
Cenrre de Recherche Labormire Chauvin. Mbnpelliu (France) 
m : Various studies suggest that changes induced in the 
cytoskeleton of cells in the trabecolar meshwork might lead to increased 
outtlow facility. The 1~11s of the trab+xlar meshwork serve as a filter for 
the aqueous httmour. We studied the effect of csrteolol on the shape and 
phagocytosis of tmbecuhu cells in vir,v. 
M&Q& : Cell culr~res derived from the @&ccttlar meshwork of bovine 
eye were incubated at 37’C with increased concenaations of carteolol, 
timolol and ethacrynic acid for different times (10 min. to 24 hours). 
Identification of actinin and B-tubulin were performed by 
immunofluorescence. The ability of cells to phagocytose latex 
microspheres was studied by electron microscopy. 
&& : Cells incubated with carte&l at high concentxations (Z 0.5 mM) 
and 0,001 mhl ethacrynic acid, show a condensation of cytoskeletal 
suoctores, a cell rcaaction and an apparent attenuation of cell-to-cell 
contacts. These. changes in cell shape were fully reversed 24 hours after 
exposure. These modifications are nca observed with timolol incubation. 
The capacity of phagocytosis of carte0101 and timolol-treated cells is not 
mod&d compared to the contml cells. 
Conclusion : A correlation between changes in tissue architecture and 
increased outflow facility is largely demonstrated for ethacrynic acid. In 
any event. results obtained from this in vitro study may not be 
extrapolated directly to in viva situation. However, these results indicate 
an impact of long-term cmtwlo1 treatment on the trabecular meshwork, 
without cytotoxic effect 
INTRAOCUJAR CONCENTRATIONS OF MJTOMYCJN C: ARE 
NEW DEVICES FOR APPJ,JCATION BENEFJCIAJf 
Mietz H.I, Diestelhorst M.1, Kriiglstein G.K.,I Hump Ah%:. ,* Thei- 
soJut M.2 
’ Depsrtmmt of OpbtbdmoIqy, University of C0108ne. Germany 
2 Institute of Ptwnscolngy, University of Celo@e, Gamsny 
m hthaoeular toxic effects of Mitomycin C (MMC) are caused by 
inadvertend pen&ration of MMC through the s&m during scleraI applica- 
tion. In most studies, a cellulose sponge is used for this procedure. We 
used different devices for aoolication in order to determine. whether these 
Methods Six eyes each of pigmented rabbits were treated with MMC with 
a wncenfration of 0.5 mg/ml. The devices used were -a cellulose sponge. - 
a s&ml shield, -a pre+.so&ed soft contact lens, -a sot? contact Lens with 
0.1 ml of MMC applied during sorgety, -a direct subconjunctival injection 
of MMC. Intraocular concentrations were measured bv HPLC fmm sam- 
ples taken 60 minutes after application of MMC. . 
&& The conceottations of MMC were highly variable within each 
4: 
mup Between the different groups, aqueous concetthations ranged from 
4 5 to 74 8 ngfd, vitreous concentxations from 3.7 to 13.2 ng/mI; 
conjtmciivs wnccntrations from 25.6 to 519.5 ng/m&; and sclera 
concenuations from 9.1 to 41.0 ng/mg. There was no statisbcal difference 
between the cancentra!ions in the tissues of the different groups. 
m This study coniirnted the intraocular penetration of high 
amounts of MMC. The use of different devices for delivew of MMC did 
not result in significantly different conceotrations in ocola; tissues except 
for subconjunctival injections with no irrigation. The high variability of 
measurements may explain the clinical phenomenon, that s4xne eyes 
develop hypotony and others not. 
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.SJBl INGUPI TIMOLOL - an al-1 medication 
alaucoma 
SADIQ S A and VERNON S A 
Department of Ophthalmology, Queen’s Medical Centre, Nottingham (UK) 
m: To assess whether timolol drops lower intraocular pressure 
(IOP) when given sublingually. This route of administration would be 
useful for glaucoma patients who are unable to instil their own drops eg. 
because of stroke, poor vision, arthritis, poor coordination, 
blepharospasm. 
Q&Q: A placebo controlled, randomised, double masked, cross 
over study. 
M&b!?Sl: 12 ocular hypertensive patients with intraocular pressures 
over PlmmHa. normal ootic discs and full visual fields by Humphrey 
perimetry. Administration‘of single dose units of timolol ialeate.0.5% 
drops and normal saline drops. Both are instilled in one eye or 
sublingually. The intraocular pressures of both eyes, pulse rate and blood 
pressure are all measured both before and after each type of drop and 
route of administration. 
5OSUltS: 2 hours after instillation of timolol in one eye, the IOP in the 
treated eye was reduced by a mean of 6.5mmHg (P=O.OOOO). and by 
1.66mmHg in the fellow aye (P=O.O267). 2 hours after sublingual 
instillation of timolol, the IOP was reduced by 7.55mmHg in the study eye 
(p=O.OOOO) and by 7.7mmHQ in the fellow eye (p=O.OOOO). 
Conclusions: Our results show that sublingual treatment is almost as 
effective as topical treatment in lowering a raised IOP. We recommend a 
trial of the sublingual route of timolol administration in patients who are 
unable to insert their own eyedrops. 
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